Guillain-Barre Syndrome

Key Points

  • Guillain-Barre syndrome is a rare autoimmune disorder causing progressive weakness and possible paralysis.
  • Weakness often begins in both legs and ascends to arms and upper body.
  • Progression can occur over hours to weeks, and respiratory-muscle involvement can be fatal.
  • Recovery commonly starts within weeks, but full recovery duration is variable and residual deficits may persist.
  • Core treatments include plasma exchange and high-dose immunoglobulin therapy.

Pathophysiology

GBS is an autoimmune-mediated peripheral nerve disorder characterized by rapidly progressive weakness, often with ascending distribution from lower to upper extremities. In severe cases, respiratory muscles are affected and life-threatening ventilatory failure can occur.

Common infectious antecedents include Campylobacter jejuni gastroenteritis and viral illnesses such as influenza, cytomegalovirus, and Epstein-Barr virus.

Classification

  • Progressive weakness phase: Rapidly evolving ascending motor weakness with possible progression to paralysis.
  • Recovery phase: Improvement usually begins within weeks but may extend over months to years.

Nursing Assessment

NCLEX Focus

Trend progression speed and respiratory involvement continuously.

  • Assess distribution and progression of weakness and paresthesia.
  • Assess for signs of respiratory-muscle compromise and fatigue.
  • Assess functional decline pace to support timely escalation.
  • Anticipate electrophysiologic support testing: NCV often shows slowed peripheral conduction in neuropathic patterns such as GBS.

Nursing Interventions

  • Escalate immediately when weakness progresses rapidly or breathing becomes compromised.
  • Coordinate definitive therapy pathways (plasma exchange and high-dose immunoglobulin) with close monitoring.
  • Support mobility safety and ADL assistance during progressive and recovery phases.

Respiratory Failure Risk

GBS can deteriorate quickly; delayed escalation can be fatal when respiratory muscles are affected.

Pharmacology

Drug ClassExamplesKey Nursing Considerations
immune-globulinsHigh-dose IVIGUsed as disease-targeted therapy to reduce autoimmune attack burden in acute GBS management.

Clinical Judgment Application

Clinical Scenario

A patient reports bilateral leg tingling that progressed to arm weakness over 48 hours with increasing shortness of breath.

  • Recognize Cues: Ascending weakness with early respiratory involvement.
  • Analyze Cues: Acute autoimmune neuropathy progression is likely.
  • Prioritize Hypotheses: Prevent respiratory failure and irreversible complications.
  • Generate Solutions: Activate urgent neurologic/respiratory monitoring and treatment pathway.
  • Take Action: Prepare for rapid supportive escalation and disease-specific therapy.
  • Evaluate Outcomes: Progression slows and respiratory status remains supported.

Self-Check

  1. Which symptom pattern is most characteristic of early GBS progression?
  2. Why is respiratory assessment a top priority in acute GBS?
  3. Which infections are commonly associated with preceding GBS onset?